Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 67
Filter
1.
Enferm Intensiva (Engl Ed) ; 35(3): 188-200, 2024.
Article in English | MEDLINE | ID: mdl-38944574

ABSTRACT

OBJECTIVE: To determine the Intensity of Collaboration between the intensive care professionals of a third level hospital. METHOD: Descriptive cross-sectional study with an analytical approach. SETTING: 6 intensive care units of a third level hospital. SAMPLE: nurses and doctors. Consecutive type non-probabilistic sampling. DATA COLLECTION: sociodemographic, economic, motivation and professional satisfaction variables, and the intensity of collaboration using the "Scale of Intensity of Interprofessional Collaboration in Health." RESULTS: A total of 102 health professionals (91 nurses and 11 doctors) were included. The mean overall Intensity of Collaboration (IoC) was moderate. Men showed higher scores in all factors (p<.05). The IoC global score was higher in the group of professionals with ≤10 years of experience (p=.043) and those who were highly satisfied with the profession (p=.037). Physicians presented higher scores in the global IdC (p=.037) and in the Collaboration mean (p=.020) independently in the multivariate models. A negative linear relationship (rho: -0,202, p=.042) was observed between age and the overall IoC score. Professionals aged ≤30years reported a higher perception of Shared Activities (p=.031). Negative linear relationships were observed between years of experience and total IoC score (rho: -0,202, p=.042) and patients' Perception score (rho: -0.241, p=0.015). The research activity also showed to be a variable related to a greater degree of Collaboration at a global level and in some of the factors (p<.05). The scale of IoC obtained a Cronbach's α of 0,9. CONCLUSIONS: The intensity of interprofessional collaboration in ICUs is moderate. Professionals with experience of ≤10 years, a higher level of satisfaction and participation in research activities show a greater intensity of collaboration. Doctors perceive collaboration more intensely than nurses. All factors contribute equally to the internal consistency of the questionnaire.


Subject(s)
Cooperative Behavior , Intensive Care Units , Interprofessional Relations , Cross-Sectional Studies , Humans , Male , Adult , Female , Middle Aged
2.
Neurologia (Engl Ed) ; 2022 Aug 09.
Article in English | MEDLINE | ID: mdl-35961506

ABSTRACT

INTRODUCTION: The analysis of the core biomarkers of Alzheimer's Disease (AD) in the cerebrospinal fluid (CSF) is recommended in the clinical units where it is available. Because of the absence of universal validated values, the determination of specific cut-off points for each center and its population is recommended. The main objective of the CORCOBIA study was to determine the cut-off points of core AD CSF biomarkers for several centers (Parc de Salut Mar, Barcelona and Hospital General de Granollers), which work with the same reference laboratory (Laboratori de Referència de Catalunya). METHODS: Prospective study including cognitively unimpaired individuals (CU, n = 42), subjects with amnestic mild cognitive impairment (aMCI, n = 35) and patients with dementia due to Alzheimer's Disease (AD, n = 48), in whom clinical and neuropsychological assessment, neuroimaging, APOE genotyping and lumbar puncture to analyse amyloid beta peptides (Aß42, Aß40), total tau (tTau) and phosphorylated Tau (pTau181) using the Lumipulse G600II (Fujirebio) was performed. The values of sensitivity (SE), specificity (SP), predictive values and area under the curve (AUC) were calculated, determining the cut-off point according to the Youden index by comparing the CU and AD groups. RESULTS: The resulting cut-offs and their AUC were the following: Aß42 750 pg/mL (AUC 0.809); Aß42/Aß40 0.062 (AUC 0.78); pTau181 69.85 pg/mL (AUC 0.81); tTau 522.0 pg/mL (AUC 0.79); Aß42/tTau 1.76 (AUC 0.86); Aß42/pTau181 10.25 (AUC 0.86). CONCLUSIONS: The determination of cut-off points of core AD CSF biomarkers for the participating centers allows a better diagnostic accuracy. The ratio CSF Aß42/pTau181 shows the highest AUC and better balance between sensitivity and specificity.

3.
Rev Clin Esp (Barc) ; 217(2): 71-78, 2017 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-27939027

ABSTRACT

OBJECTIVES: To estimate the prevalence of obesity in patients treated by departments of Internal Medicine and to classify the patients according to the Edmonton Obesity Staging System (EOSS). MATERIAL AND METHODS: An observational, descriptive cross-sectional study included outpatients older than 18 years, with a body mass index (BMI)>30, from 38 hospitals between the 1st and 14th of February, 2016. We classified the patients according to the EOSS and analysed their clinical, laboratory and demographic variables. A value of P<.05 was considered statistically significant. RESULTS: Of the 1,262 patients treated in consultations, we recruited 298 and analysed 265. The prevalence of obesity was 23.6%, the mean age was 62.47±15.27 years, and the mean BMI was 36.1±5.3kg/m2. According to EOSS stage (0, 1, 2, 3 and 4), the prevalence was 4.9, 14.7, 62.3, 15.5 and 2.64%, respectively. Those patients with EOSS>2 were significantly older and had significantly more comorbidities. The multivariate analysis related age (OR 1.06; P<.0003), blood glucose (OR 1.04; P<.0006), total cholesterol (OR 0.98; P<.02) and uric acid (OR 1.32; P<.02) levels with an EOSS>2. An analysis of correspondence grouped, with an explanatory percentage of 78.2%, the patients according to their EOSS, comorbidity, education level, employment status and functional capacity. CONCLUSIONS: The prevalence of obesity in the patients treated by Internal Medicine departments is similar to that of the general population, although the patients are older and have a higher BMI. EOSS is useful for implementing a comprehensive approach for patients with obesity, regardless of the BMI, which can help achieve better health and quality-of-life results.

4.
Drug Test Anal ; 5(8): 619-26, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23339119

ABSTRACT

The urinary steroid profile has been used in clinical endocrinology for the early detection of enzyme deficiencies. In the field of doping, its evaluation in urine samples is used to diagnose the abuse of substances prohibited in sport. This profile is influenced by sex, age, exercise, diet, and ethnicity, among others; laboratories own reference ranges might compensate for ethnic differences among population and inter-laboratory biases. This paper shows the reference ranges obtained in the Antidoping Laboratory of Havana for the following steroid profile parameters: ten androgens (testosterone, epitestosterone, androsterone, etiocholanolone, 5α-androstan-3α,17ß-diol, 5ß-androstan-3α,17ß-diol, dehydroepiandrosterone, epiandrosterone, 11ß-hydroxyandrosterone and 11ß-hydroxyetiocholanolone), three estrogens (estradiol, estriol and estrone), two pregnanes (pregnanediol and pregnanetriol) and two corticosteroids (cortisol and tetrahydrocortisol). The urine samples (male: n = 2454 and female: n = 1181) and data obtained are representative of population from Latin-American countries like Cuba, Venezuela, Mexico, Dominican Republic, Guatemala and Chile. Urine samples were prepared by solid-phase extraction followed by enzymatic hydrolysis and liquid-liquid extraction with an organic solvent in basic conditions. Trimethylsilyl derivatives were analyzed by gas chromatography coupled to mass spectrometry. Reference ranges were established for each sex, allowing the determination of abnormal profiles as a first diagnostic tool for the detection of the abuse of androgenic anabolic steroids. The comparison with the Caucasian population confirms that the urinary steroid profile is influenced by ethnicity.


Subject(s)
Gas Chromatography-Mass Spectrometry/methods , Steroids/urine , Substance Abuse Detection/methods , Adrenal Cortex Hormones/urine , Androgens/urine , Doping in Sports , Estrogens/urine , Female , Gas Chromatography-Mass Spectrometry/standards , Hispanic or Latino , Humans , Latin America , Male , Pregnanediol/urine , Pregnanetriol/urine , Reference Values , Sensitivity and Specificity , Substance Abuse Detection/standards
5.
Arch Soc Esp Oftalmol ; 80(9): 497-509, 2005 Sep.
Article in Spanish | MEDLINE | ID: mdl-16193432

ABSTRACT

OBJECTIVE: Corneal refractive surgery involves a range of techniques which have assumed a growing importance during the last few years. The advances of very different surgical methods and the early age of the majority of the patients subjected to surgery, limits our knowledge of the histopathologic changes in the operated corneas. For this reason, the development of any diagnostic tool which can permit us to improve our knowledge of the wound healing process would be of significant value. As we describe in our paper, confocal microscopy enables the assessment of the more important advantages for the study of corneal wound healing after refractive surgery: high magnification, harmless, and "in vivo", providing pathogenic information and lateral and axial definition not achievable with other exploration techniques. CONCLUSION: Confocal microscopy appears to be an essential tool for creating a global concept of quality in corneal refractive surgery.


Subject(s)
Keratomileusis, Laser In Situ , Microscopy, Confocal , Photorefractive Keratectomy , Cicatrix/pathology , Cornea/anatomy & histology , Cornea/pathology , Corneal Stroma/anatomy & histology , Corneal Stroma/pathology , Follow-Up Studies , Humans , Lasers, Excimer , Microscopy, Confocal/methods , Surgical Flaps , Time Factors , Wound Healing
8.
Br J Ophthalmol ; 87(2): 142-6, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12543737

ABSTRACT

AIMS: To ascertain the prevalence of acute trachoma as a supposed endemic disease among infants in the Saharan refugee camps of Tindouf (Algeria) and to evaluate the efficacy of treatment with a single dose of azithromycin. METHODS: 527 children aged between 3 and 17 were evaluated in the camp schools in October 2001. All the children were clinically and microbiologically examined, including slit lamp checks of anterior segment and two conjunctival swabs, one for the detection of membrane lipopolysaccharide by quick immunoassay test Clearview Chlamydia MF and the other for the detection of specific DNA by chlamydia plasmid specific polymerase chain reaction (PCR) assay. After examination, a single dose of azithromycin was administered to each child. One month later samples from positive children and 12 random negative children by the first PCR were taken to perform a new PCR assay. RESULTS: Chlamydia trachomatis was suspected in 2.47% of the children, papillary hypertrophy being the most frequently seen clinical sign. Scarring changes secondary to trachoma were detected in 11.7% of the children. Only four cases (0.8%) were positive to the immunoassay test and 12 cases (2.27%) were positive by PCR. After treatment a second PCR was performed on positive children and they were negative of chlamydia DNA amplification. However, one child who was negative and received the treatment was positive in the second PCR assay. CONCLUSION: Acute trachoma prevalence is much lower than expected among infants in this Saharan population. The possible reasons could be the recent improvements in hygiene and health care. Cicatricial trachoma is more frequent. The Clearview immunoassay test has very low sensitivity in the detection of this disease. A single dose of azithromycin is sufficient to treat chlamydial conjunctivitis. However, a programme of improvement in hygiene and health care is necessary to prevent re-infection.


Subject(s)
Chlamydia trachomatis , Trachoma/epidemiology , Acute Disease , Adolescent , Algeria/epidemiology , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Child , Child, Preschool , DNA, Bacterial/analysis , Epitopes/analysis , Female , Humans , Lipopolysaccharides/analysis , Male , Nucleic Acid Amplification Techniques/methods , Polymerase Chain Reaction , Prevalence , Refugees , Trachoma/drug therapy , Trachoma/microbiology
9.
Talanta ; 59(3): 591-9, 2003 Mar 01.
Article in English | MEDLINE | ID: mdl-18968944

ABSTRACT

2-Phenylbenzimidazole-5-sulphonic acid (PBS) is an UV-filter contained in many cosmetics as a sunscreen. A direct, selective and sensitive method to determine traces of PBS is presented. The on-line separation of this compound from urine matrix was directly coupled with fluorimetric detection in a sequential-injection system. The separation was performed using a SAX microcolumn in which the analyte was retained and eluted selectively. The determination is carried out without any derivatization reaction, by directly measuring the intrinsic fluorescence of the analyte. The wavelengths of excitation and emission were 301 and 681 nm, respectively. On-line standard addition calibration is performed into the system, and only one standard solution is required. The limit of detection was 12 ng ml(-1). The method was satisfactorily used to determine PBS in both, spiked and unspiked human urine samples, without any pretreatment. The relative standard deviations of the results were in the order of 2-13%. The concentrations of the analyte obtained for unspiked samples taken from sunscreen users were higher than the limit of detection.

12.
Am J Gastroenterol ; 94(4): 1070-6, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10201485

ABSTRACT

OBJECTIVE: Angiodysplasia of the colon is a distinct vascular abnormality characterized by focal accumulation of ectatic vessels in the mucosa and submucosa. To investigate whether angiogenesis contributes to the pathogenesis of human colonic angiodysplasia, we examined the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), and its endothelial cell receptors flt-1 and KDR. METHODS: Immunohistochemistry was performed in sections of specimens obtained from 18 patients with colonic angiodysplasia and from eight patients with colon cancer and its adjacent, histologically normal margins of resection. We used affinity-purified rabbit polyclonal antibodies and a streptoavidin-biotin peroxidase method. RESULTS: We detected strong immunoreactivity for vascular endothelial growth factor, homogeneously distributed in the endothelial lining of blood vessels of all sizes in 16 (89%) specimens of colonic angiodysplasia and in seven (88%) patients with colon cancer. In contrast, very limited immunoreactivity was found in normal colon. Vascular staining for flt-1 was observed in eight (44%) and one (12.5%) of the colonic angiodysplasia or colon cancer specimens, respectively, but not in normal colon. Vascular immunoreactivity for basic fibroblast growth factor was observed in seven (39%) specimens from patients with colonic angiodysplasia, whereas either very limited or no immunostaining was found in sections from specimens of patients with colon cancer and its normal margins. CONCLUSIONS: In human colonic angiodysplasia, increased expression of angiogenic factors is likely to play a pathogenic role.


Subject(s)
Angiodysplasia/metabolism , Colon/blood supply , Endothelial Growth Factors/biosynthesis , Fibroblast Growth Factor 2/biosynthesis , Lymphokines/biosynthesis , Adenocarcinoma/metabolism , Aged , Aged, 80 and over , Animals , Case-Control Studies , Colonic Neoplasms/metabolism , Female , Humans , Immunoenzyme Techniques , Male , Middle Aged , Rabbits , Receptor Protein-Tyrosine Kinases/biosynthesis , Receptors, Growth Factor/biosynthesis , Receptors, Mitogen/biosynthesis , Receptors, Vascular Endothelial Growth Factor , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
13.
Brain Res ; 796(1-2): 311-4, 1998 Jun 15.
Article in English | MEDLINE | ID: mdl-9689485

ABSTRACT

In animal models of epilepsy, calcium entry blockers have shown anticonvulsant properties. We studied the antiepileptic effects of nimodipine and two novel dihydropyridines, a calcium antagonist (PCA 50922) and a calcium agonist (PCA 50941), on pentylenetetrazole seizure and maximal electroshock seizure (MES) in mice. Anticonvulsant profile of nimodipine and PCA 50922 was similar to that of clonazepam, but markedly different from that of phenytoin. None of the doses of the PCA 50941 showed anticonvulsant effect.


Subject(s)
Anticonvulsants/therapeutic use , Calcium Channel Agonists/therapeutic use , Calcium Channel Blockers/therapeutic use , Dihydropyridines/pharmacology , Dihydropyridines/therapeutic use , Nimodipine/therapeutic use , Seizures/drug therapy , Thiazoles/therapeutic use , Animals , Clonazepam/therapeutic use , Electroshock , Female , Male , Mice , Mice, Inbred Strains , Pentylenetetrazole , Phenytoin/therapeutic use , Seizures/chemically induced , Seizures/etiology
14.
J Clin Pathol ; 50(2): 168-70, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9155703

ABSTRACT

The aim was to evaluate Leu-M1 immunoreactivity as a prognostic factor in phaeochromocytoma. Anti-Leu-M1 monoclonal antibodies were used to determine the Leu-M1 immunoreactivity in 17 histologically confirmed phaeochromocytomas from 15 patients, using an avidin-biotin technique. Ten patients had a sporadic phaeochromocytoma, and five had multiple endocrine neoplasia type 2A (MEN 2A). Malignancy was diagnosed in three patients by the presence of metastases. Leu-M1 immunoreactivity was shown in 12 (70.5%) phaeochromocytomas. Three patterns of arrangement were observed: isolated (scattered positive cells) (n = 3); focal (aggregates of positive cells) (n = 5), and diffuse patterns (dispersed positive cells) (n = 4). Two cases of malignant phaeochromocytoma were positive (one focal and one isolated pattern). All cases of MEN 2A showed immunoreactivity, although no characteristic pattern was prevalent. A diffuse pattern was observed in all phaeochromocytomas longer than 7 cm. In conclusion, Leu-M1 expression is frequent in phaeochromocytoma. However, Leu-M1 immunoreactivity seems to be useless in predicting malignant behaviour and to be influenced mainly by tumour size.


Subject(s)
Adrenal Gland Neoplasms/metabolism , Lewis X Antigen/metabolism , Pheochromocytoma/metabolism , Adrenal Gland Neoplasms/complications , Adult , Aged , Female , Humans , Immunohistochemistry , Male , Middle Aged , Multiple Endocrine Neoplasia Type 2a/complications , Multiple Endocrine Neoplasia Type 2a/metabolism , Pheochromocytoma/complications , Prognosis
15.
Rev Enferm ; 20(229): 59-65, 1997 Sep.
Article in Spanish | MEDLINE | ID: mdl-9385192

ABSTRACT

Since the introduction of insulin as a treatment for diabetes the drop in mortality due to diabetic ketosis has dropped from 60% to 5%. This article explains the physiopathology of diabetic ketosis, its characteristic signs and symptoms, and what actions should be taken if one encounters a patient affected this syndrome. Emphasis has been placed on presenting exact nursing diagnoses and procedures, according to the diagnostic taxonomy of NANDA, with special regard to the interdependent problems which might arise due to the pathology of the disease and its treatment.


Subject(s)
Diabetic Ketoacidosis/nursing , Nursing Diagnosis , Patient Care Planning , Diabetic Ketoacidosis/metabolism , Diabetic Ketoacidosis/physiopathology , Humans
16.
Rev Esp Cardiol ; 48(10): 690-2, 1995 Oct.
Article in Spanish | MEDLINE | ID: mdl-7481039

ABSTRACT

We report a 67-years-old patient with angina pectoris and positive treadmill test. In the coronary arteriography the left coronary artery arose from the right coronary sinus of Valsalva through an independent ostium and followed a retroaortic course. Coronary artery disease was no demonstrated, so we thought that the myocardial ischaemia shown in the treadmill test, was due to the anomalous origin of the left coronary artery. Surgical treatment was recommended.


Subject(s)
Coronary Vessel Anomalies/diagnosis , Aged , Angina Pectoris/diagnosis , Angina Pectoris/etiology , Aorta , Coronary Vessel Anomalies/complications , Female , Humans , Myocardial Ischemia/diagnosis , Myocardial Ischemia/etiology , Physical Exertion , Sinus of Valsalva/abnormalities
18.
Med Clin (Barc) ; 105(1): 5-8, 1995 Jun 03.
Article in Spanish | MEDLINE | ID: mdl-7637419

ABSTRACT

BACKGROUND: Among 20 to 30% of the patients with ovarian cancer present overexpression of the c-erbB protein in the tumor tissue although its clinical significance has not been clearly established. In patients with a disseminated neoplasm and overexpression of c-erbB an increase in the extracellular portion of this protein may be detected in serum. The aim of this study was to determine the c-erbB protein in serum and in tumoral tissue in patients diagnosed with ovarian epithelial carcinoma. METHODS: The serum concentration of the c-erbB protein was quantified by ELISA techniques in 60 blood donor women (control group) and in 99 patients with ovarian cancer. Likewise, the expression of the c-erbB protein was determined in tumoral tissue by immunohistochemical techniques in the 99 patients with ovarian cancer. The correlation between overexpression and elevated serum values was analyzed. RESULTS: The mean c-erbB values obtained in the serum of the control group was 10.9 U/ml (SD: 2.8) with a range of 1.5-17.0. Serum determination was carried out in absence of the tumor in 49 patients being positive in 2 cases. In 7 patients the determination was performed in the presence of peritoneal implants of a diameter of less than 2 cm with none being positive. Serum determination was carried out in 43 patients in the presence of implants greater than 2 cm and 14 (32.5%) were positive. A further 153 determinations were performed during follow up of the 99 patients, 62 in tumor absence (3.2% positive), 2 in the presence of a tumor of less than 2 cm (none positive) and 89 in the presence of a tumor greater than 2 cm (34.8% positive). A correlation was found between elevated c-erbB serum values in the presence of a disseminated tumors and overexpression of tumoral tissue (p: 0.0011). CONCLUSIONS: A third of the patients with ovarian cancer and peritoneal implants of a diameter greater than 2 cm present elevated serum levels of the c-erbB.2 protein. A correlation was found between serum c-erbB positivity and overexpression of the protein in tumoral tissue.


Subject(s)
Carcinoma/metabolism , Gene Expression Regulation, Neoplastic , Ovarian Neoplasms/metabolism , Receptor, ErbB-2/metabolism , Carcinoma/genetics , Case-Control Studies , Female , Humans , Ovarian Neoplasms/genetics
19.
Cancer ; 75(8): 2147-52, 1995 Apr 15.
Article in English | MEDLINE | ID: mdl-7697606

ABSTRACT

BACKGROUND: Overexpression of the c-erbB-2 protein has been reported in tumors from approximately 25% of patients with epithelial ovarian cancer. However, its clinical significance has not been well established. METHODS: Overexpression of the c-erbB-2 protein was studied by immunohistochemistry in paraffin-embedded tumor tissue from 106 patients with ovarian cancer. RESULTS: Tumors from 23 patients (21.7%) had c-erbB-2 overexpression. The percentage of tumors with overexpression was higher in those with Stages III/IV disease (29.2%) compared with those with Stages I/II disease (5.9%) (P = 0.057), in patients with residual tumor greater than 2 cm after initial surgery (37.2%) compared with those with tumor less than 2 cm (9.5%) (P = 0.01), and in patients who failed to respond to chemotherapy with carboplatin and cyclophosphamide (75%) compared with those who responded (18.6%) (P = 0.0043). No correlation was found between c-erbB-2 expression with age, the degree of differentiation, or the histologic subtype. Median survival of the 23 patients with protein overexpression was 62 weeks, whereas 75% of the 83 patients without overexpression were alive at 123 weeks (P = 0.0000). Of the patients with advanced stage disease (III/IV), survival was also lower in those presenting with overexpression (60 weeks) compared with those without expression (75% alive at 93 weeks) (P = 0.0000). Multivariate analysis of possible prognostic factors showed that c-erbB-2 overexpression and residual tumor greater than 2 cm resulted in a worsening of survival rates. CONCLUSION: c-erbB-2 overexpression in tumors from patients with ovarian cancer resulted in a poorer prognosis than for patients whose tumors did not have overexpression.


Subject(s)
Ovarian Neoplasms/metabolism , Receptor, ErbB-2/biosynthesis , Adult , Aged , Female , Humans , Immunoenzyme Techniques , Middle Aged , Multivariate Analysis , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/mortality , Prognosis , Receptor, ErbB-2/analysis , Survival Analysis
20.
Int J Cardiol ; 43(2): 199-201, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8181874

ABSTRACT

A patient, diagnosed with coarctation of the aorta at the age of 59, was found to have a pulmonary mass in his right upper lobe. A chest scan and digital intravenous arteriography revealed a right artery subclavian aneurysm. Such an unusual association is described.


Subject(s)
Aneurysm/complications , Aortic Coarctation/complications , Subclavian Artery , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...